Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,135	15,403	10,379	5,459	8,215	9,018
Market Cap Growth	2.36%	48.41%	90.12%	-33.55%	-8.90%	99.42%
Enterprise Value	8,848	14,978	9,810	5,150	7,936	8,417
Last Close Price	290.00	489.00	329.50	183.00	278.50	314.00
PE Ratio	67.00	89.46	113.04	296.26	1007.78	-
Forward PE	47.50	92.61	199.34	111.93	211.39	288.07
PS Ratio	10.68	18.73	17.37	13.15	31.80	50.14
PB Ratio	4.37	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	6.47	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	388.44	379.77	3172.09	564.50	-	-
P/OCF Ratio	96.72	138.41	224.23	195.98	-	-
EV/Sales Ratio	10.35	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	66.91	135.06	515.41	387.15	-	-
EV/EBIT Ratio	91.24	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	376.25	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.01	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.22	0.28	1.06	0.51	-	-
Debt / FCF Ratio	1.25	0.84	9.61	1.03	-	-
Asset Turnover	0.38	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.13	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.59	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.20	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	6.69%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	2.67%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.92%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	4.50%	4.00%	0.30%	0.30%	-	-
Earnings Yield	1.50%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	0.26%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-4.40%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.